BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Total Liabilities

Latest as of March 2026: Rs879.53 Million INR ≈ $9.51 Million USD

Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has total liabilities worth Rs879.53 Million INR (≈ $9.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BALAXI PHARMACEUTICALS LIMITED (BALAXI) investment intensity to see how much of total assets are deployed in long-term investments.

BALAXI PHARMACEUTICALS LIMITED - Total Liabilities Trend (2013–2026)

This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BALAXI total asset value.

BALAXI PHARMACEUTICALS LIMITED Competitors by Total Liabilities

The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their total liabilities.

Company	Country	Total Liabilities
Artroniq Berhad KLSE:0038	Malaysia	RM5.88 Million
ERSU Meyve ve Gida Sanayi AS IS:ERSU	Turkey	TL261.90 Million
INOVIQ LTD. F:EGQ0	Germany	€1.72 Million
Serstech AB ST:SERT	Sweden	Skr8.52 Million
MYMBN Berhad KLSE:0280	Malaysia	RM7.12 Million
PIMS Inc. KQ:347770	Korea	₩39.03 Billion
MMS Ventures Bhd KLSE:0113	Malaysia	RM6.41 Million
Akritas S.A AT:AKRIT	Greece	€55.99 Million

Liability Composition Analysis (2013–2026)

This chart breaks down BALAXI PHARMACEUTICALS LIMITED's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BALAXI equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BALAXI PHARMACEUTICALS LIMITED's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BALAXI PHARMACEUTICALS LIMITED (2013–2026)

The table below shows the annual total liabilities of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs879.53 Million ≈ $9.51 Million	+11.89%
2025-03-31	Rs786.06 Million ≈ $8.50 Million	+37.96%
2024-03-31	Rs569.79 Million ≈ $6.16 Million	+0.33%
2023-03-31	Rs567.89 Million ≈ $6.14 Million	-10.29%
2022-03-31	Rs633.07 Million ≈ $6.85 Million	+82.44%
2021-03-31	Rs347.00 Million ≈ $3.75 Million	+321.88%
2020-03-31	Rs82.25 Million ≈ $889.51K	+217.90%
2019-03-31	Rs25.87 Million ≈ $279.81K	+1859.33%
2018-03-31	Rs1.32 Million ≈ $14.28K	-39.26%
2017-03-31	Rs2.17 Million ≈ $23.51K	+5061.73%
2016-03-31	Rs42.12K ≈ $455.50	-7.73%
2015-03-31	Rs45.65K ≈ $493.67	-98.92%
2014-03-31	Rs4.24 Million ≈ $45.88K	-12.73%
2013-03-31	Rs4.86 Million ≈ $52.57K	--

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Drug Manufacturers - Specialty & Generic

Market Cap

$14.06 Million

Rs1.30 Billion INR

Market Cap Rank

#26264 Global

#1447 in India

Share Price

Rs23.55

Change (1 day)

+2.21%

52-Week Range

Rs15.67 - Rs47.01

All Time High

Rs207.74